[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 784 Agreed to Senate (ATS)]

<DOC>






116th CONGRESS
  2d Session
S. RES. 784

      Supporting the goals and ideals of American Diabetes Month.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            December 2, 2020

  Mrs. Shaheen (for herself and Ms. Collins) submitted the following 
             resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION


 
      Supporting the goals and ideals of American Diabetes Month.

Whereas, according to the Centers for Disease Control and Prevention (referred 
        to in this preamble as the ``CDC'')--

    (1) 34,200,000 individuals in the United States have diabetes; and

    (2) an estimated 88,000,000 individuals in the United States who are 18 
years of age or older have prediabetes;

Whereas diabetes is a serious chronic condition that affects individuals of 
        every age, race, ethnicity, and income level;
Whereas the CDC reports that--

    (1) Hispanic Americans, African Americans, Asian Americans, and Native 
Americans are disproportionately affected by diabetes and develop the 
disease at much higher rates than the general population of the United 
States; and

    (2) an estimated 21.4 percent of individuals with diabetes in the 
United States have not yet been diagnosed with the disease;

Whereas, in the United States, more than 10.5 percent of the population, 
        including 26.8 percent of individuals who are 65 years of age or older, 
        have diabetes;
Whereas, of the 17,400,000 veterans in the United States, 8,800,000 who are 65 
        years of age or older, and 1 in 4 overall, are receiving care for 
        diabetes from the Department of Veterans Affairs;
Whereas the risk of developing diabetes at some point in life is 40 percent for 
        adults in the United States;
Whereas, according to the American Diabetes Association, the United States spent 
        an estimated $237,000,000,000 on direct medical costs for cases of 
        diagnosed diabetes in 2017, and out-of-pocket costs for insulin have 
        grown significantly in recent years for many patients;
Whereas the American Diabetes Association reports that care for people with 
        diagnosed diabetes accounts for 1 in 4 health care dollars spent in the 
        United States;
Whereas the cost of health care is estimated to be 2.3 times higher for 
        individuals in the United States with diabetes than those without 
        diabetes;
Whereas, as of November 2020, a cure for diabetes does not exist;
Whereas there are successful means to reduce the incidence, and delay the onset, 
        of type 2 diabetes;
Whereas, with proper management and treatment, individuals with diabetes live 
        healthy and productive lives; and
Whereas individuals in the United States celebrate American Diabetes Month in 
        November: Now, therefore, be it
    Resolved, That the Senate--
            (1) supports the goals and ideals of American Diabetes 
        Month, including--
                    (A) encouraging individuals in the United States to 
                fight diabetes through public awareness of prevention 
                and treatment options; and
                    (B) enhancing diabetes education;
            (2) recognizes the importance of awareness and early 
        detection, including awareness of symptoms and risk factors 
        such as--
                    (A) being--
                            (i) older than 45 years of age; or
                            (ii) overweight; and
                    (B) having--
                            (i) a particular racial and ethnic 
                        background;
                            (ii) a low level of physical activity;
                            (iii) high blood pressure;
                            (iv) a family history of diabetes; or
                            (v) a history of diabetes during pregnancy;
            (3) supports decreasing the prevalence of type 1, type 2, 
        and gestational diabetes in the United States through research, 
        treatment, and prevention; and
            (4) recognizes the importance of addressing systemic 
        barriers to health care that--
                    (A) leave many vulnerable communities at a 
                heightened risk for diabetes; and
                    (B) limit access to health care resources that are 
                needed to effectively prevent the onset, and to manage 
                the condition, of diabetes.
                                 <all>